HUP0003438A3 - Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates - Google Patents

Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates

Info

Publication number
HUP0003438A3
HUP0003438A3 HU0003438A HUP0003438A HUP0003438A3 HU P0003438 A3 HUP0003438 A3 HU P0003438A3 HU 0003438 A HU0003438 A HU 0003438A HU P0003438 A HUP0003438 A HU P0003438A HU P0003438 A3 HUP0003438 A3 HU P0003438A3
Authority
HU
Hungary
Prior art keywords
pirrole
carboxamid
intermediates
derivatives
making
Prior art date
Application number
HU0003438A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0003438D0 publication Critical patent/HU0003438D0/hu
Publication of HUP0003438A2 publication Critical patent/HUP0003438A2/hu
Publication of HUP0003438A3 publication Critical patent/HUP0003438A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU0003438A 1999-08-31 2000-08-30 Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates HUP0003438A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161199P 1999-08-31 1999-08-31

Publications (3)

Publication Number Publication Date
HU0003438D0 HU0003438D0 (en) 2000-08-30
HUP0003438A2 HUP0003438A2 (hu) 2001-08-28
HUP0003438A3 true HUP0003438A3 (en) 2002-08-28

Family

ID=22539515

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003438A HUP0003438A3 (en) 1999-08-31 2000-08-30 Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates

Country Status (19)

Country Link
US (1) US6344563B1 (hu)
EP (1) EP1081146A1 (hu)
JP (1) JP2001106687A (hu)
KR (1) KR20010050224A (hu)
CN (1) CN1291609A (hu)
AR (1) AR022649A1 (hu)
AU (1) AU5360700A (hu)
BR (1) BR0003875A (hu)
CA (1) CA2317001A1 (hu)
CZ (1) CZ20003160A3 (hu)
HU (1) HUP0003438A3 (hu)
ID (1) ID29315A (hu)
IL (1) IL138088A0 (hu)
MX (1) MXPA00008505A (hu)
PL (1) PL342284A1 (hu)
RU (1) RU2177005C1 (hu)
TR (1) TR200002523A2 (hu)
YU (1) YU52800A (hu)
ZA (1) ZA200004436B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5132861B2 (ja) 2000-03-24 2013-01-30 ユーロ−セルティック エス． ア． ナトリウムチャネル遮断薬としてのアリール置換ピラゾール、トリアゾールおよびテトラゾール
EP3791880A1 (en) 2009-04-29 2021-03-17 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9406822A (pt) * 1993-06-14 1996-03-26 Pfizer Inibidores imidazol de lipoxigenase
SK281577B6 (sk) 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
US6063928A (en) * 1994-10-18 2000-05-16 Pfizer Inc 5-lipoxygenase inhibitors
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
PT863905E (pt) * 1995-09-18 2001-03-30 Pfizer Novos inibidores da lipoxigenase do imidazolo

Also Published As

Publication number Publication date
BR0003875A (pt) 2001-12-11
MXPA00008505A (es) 2005-07-25
AU5360700A (en) 2001-03-08
EP1081146A1 (en) 2001-03-07
CZ20003160A3 (cs) 2001-10-17
KR20010050224A (ko) 2001-06-15
PL342284A1 (en) 2001-03-12
HU0003438D0 (en) 2000-08-30
IL138088A0 (en) 2001-10-31
YU52800A (sh) 2003-08-29
TR200002523A2 (tr) 2001-04-20
US6344563B1 (en) 2002-02-05
HUP0003438A2 (hu) 2001-08-28
CA2317001A1 (en) 2001-02-28
ID29315A (id) 2001-08-16
CN1291609A (zh) 2001-04-18
RU2177005C1 (ru) 2001-12-20
AR022649A1 (es) 2002-09-04
ZA200004436B (en) 2002-02-28
JP2001106687A (ja) 2001-04-17

Similar Documents

Publication Publication Date Title
PL353002A1 (en) Hemisynthetic method and intermediates thereof
AU2001294549A1 (en) Process and intermediates
HUP0400642A3 (en) Coupling process and intermediates useful for preparing cephalosphorins
GB2353974B (en) Method of printing
GB9927302D0 (en) Chemical process and intermediates
GB0020717D0 (en) Novel compounds and process
GB9920636D0 (en) Custom coupon process
HUP0003438A3 (en) Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates
HUP0003439A3 (en) Process for making 5-lipoxygenase inhibitor pyrrole-carboxamid-derivatives and their intermediates
HU9904282D0 (en) Process and intermediates for preparing 5-lipoxygenase inhibitors
HUP0003862A3 (en) Acylation process
HUP0203543A3 (en) Process to prepare aryltriazolinones and novel intermediates thereto
GB9915626D0 (en) Process and composition for water recycle
IL136726A0 (en) Novel processes and intermediates
HUP9900121A3 (en) Process for producing naphthyridones and intermediates
GB2385588B (en) Corrosion inhibitor compounds and process for production thereof
AU4295100A (en) Process and intermediates for preparing benzodiazepines
GB9910989D0 (en) Metal cleaning process
GB0013204D0 (en) Novel process and intermediates
PL333334A1 (en) Method of obtaining silylethenes
HUP0204270A3 (en) Process for preparing cyclohexancarbonitrile derivatives and their intermediates
HUP9903281A3 (en) Method for recycling of grogs
HK1049145A1 (zh) 4-氰基取代的環己酸的製備方法和中間體
HU9904584D0 (en) Chemical process and new intermediates
PL336550A1 (en) Method of decoposing 2-chloroethenylchloroarsazine